| Literature DB >> 26773605 |
Heloisa I G Giamberardin1, Sheila Homsani2, Lucia F Bricks2, Ana P O Pacheco1, Matilde Guedes1, Maria C Debur3, Sonia M Raboni4.
Abstract
This study reports the results of a systematic screening for respiratory viruses in pediatric outpatients from an emergency department (ED) in southern Brazil during two consecutive influenza seasons. Children eligible for enrollment in this study were aged 24-59 months and presented with acute respiratory symptoms and fever. Naso- and oropharyngeal swabs were collected and multiplex reverse transcription PCR (RT-PCR) was performed to identify the respiratory viruses involved. In total, 492 children were included in this study: 248 in 2010 and 244 in 2011. In 2010, 136 samples (55%) were found to be positive for at least one virus and the most frequently detected viruses were human rhinovirus (HRV) (18%), adenovirus (AdV) (13%), and human coronavirus (CoV) (5%). In 2011, 158 samples (65%) were found to be positive for at least one virus, and the most frequently detected were HRV (29%), AdV (12%), and enterovirus (9%). Further, the presence of asthma (OR, 3.17; 95% CI, 1.86-5.46) was independently associated with HRV infection, whereas fever was associated with AdV (OR, 3.86; 95% CI, 1.31-16.52) and influenza infections (OR, 3.74; 95% CI, 1.26-16.06). Ten patients (2%) were diagnosed with pneumonia, and six of these tested positive for viral infection (4 HRV, 1 RSV, and 1 AdV). Thus, this study identified the most common respiratory viruses found in preschool children in the study region and demonstrated their high frequency, highlighting the need for improved data collection, and case management in order to stimulate preventive measures against these infections. J. Med. Virol. 88:1325-1333, 2016.Entities:
Keywords: community respiratory virus; influenza; pediatric respiratory infection; vaccine
Mesh:
Year: 2016 PMID: 26773605 PMCID: PMC7167150 DOI: 10.1002/jmv.24477
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327
Demographic, Clinical, and Epidemiological Data from the 492 Children Enrolled in the Study in Southern Brazil
| Data | N = 492 (%) |
|---|---|
| Sex | |
| Female | 227 (46) |
| Male | 265 (54) |
| Age (months) | |
| Mean ± SD | 39.1 ± 10.2 |
| Median (min–max) | 38.3 (24.0–60.0) |
| Enrolled in school/day‐care centers | |
| No | 112 (23) |
| Yes | 376 (77) |
| Part‐time school | 158 (42) |
| Full‐time school | 218 (58) |
| Comorbid conditions | |
| No | 342 (69.8) |
| Yes | 149 (30) |
| Unknown | 1 (0.2) |
| Type of comorbidity present | |
| Asthma and/or bronchitis | 129 (26) |
| Allergic rhinitis | 36 (7) |
| Other | 29 (12) |
| Passive smoking | |
| No | 184 (76) |
| Yes | 57 (24) |
Clinical Manifestations, Radiological Findings, and Diagnoses of the Enrolled Subjects
| Data | N = 492 (%) |
|---|---|
| Fever | 107 (22%) |
| No | 385 (78) |
| Yes | |
| Cough | |
| No | 140 (28) |
| Yes | 352 (72) |
| Coryza | 298 (61) |
| No | 194 (39) |
| Yes | |
| Pharyngeal erythema | 160 (32) |
| No | 332 (68) |
| Yes | |
| Wheezing | 427 (87) |
| No | 65 (13) |
| Yes | |
| Dyspnea | 464 (94) |
| No | 28 (6) |
| Yes | |
| Antibiotics used | |
| Yes | 34 (7) |
| Amoxicillin | 12 (35) |
| Amoxicillin clavulanate | 6 (15) |
| Benzathine penicillin | 5 (15) |
| Azithromycin | 4 (12) |
| Ceftriaxone | 2 (6) |
| Others | 5 (6) |
| Respiratory support needed | |
| No | 483 (98) |
| Yes | 9 (2) |
| Radiological assessment performed | |
| Yes | 44 (9) |
| Normal | 7 (16) |
| Perihilar infiltrate | 27 (61) |
| Pulmonary consolidation | 10 (23) |
| Most frequent diagnoses | |
| Nasopharyngitis | 255 (52) |
| Influenza‐like infection | 96 (19) |
| Asthma/bronchitis | 48 (10) |
| Tonsillitis | 42 (8) |
| Pharyngitis | 24 (5) |
| Acute laryngitis | 14 (3) |
| Pneumonia | 13 (3) |
| Bronchospasm crisis | 12 (2) |
Respiratory Viruses Identified in Pediatric Outpatients in Southern Brazil in 2010 and 2011
| 2010 | 2011 | |
|---|---|---|
| Results from nasopharyngeal swab exudates: viral mono‐ and co‐detection | N = 248 (%) | N = 244 (%) |
| Samples | ||
| Positive | 136 (55) | 157 (65) |
| Negative | 112 (45) | 86 (35) |
| One virus | 118 (48) | 132 (54) |
| Two viruses | 17 (7) | 26 (11) |
| Three viruses | 1 (0.4) | — |
| Viruses detected | ||
| Human rhinovirus A/B | 46 (18) | 71 (29) |
| Human adenovirus | 33 (13) | 29 (12) |
| Human enterovirus | — | 21 (9) |
| Human coronavirus 229/NL 63 | 13 (5) | 3 (1) |
| Influenza virus B | 11 (4) | 14 (6) |
| Parainfluenza virus 3 | 11 (4) | 17 (7) |
| Human metapneumovirus | 11 (4) | 8 (3) |
| Influenza virus A | 9 (3) | 9 (4) |
| Human coronavirus OC43/HKU1 | 9 (3) | 3 (1) |
| Parainfluenza virus 4 | — | 5 (2) |
| Parainfluenza virus 1 | 5 (2) | 1 (0.4) |
| Respiratory syncytial virus B | 3 (1) | — |
| Respiratory syncytial virus A | 2 (0.8) | 2 (0.8) |
| Influenza A non‐typed | 1 (0.4) | — |
| Parainfluenza virus 2 | 1 (0.4) | — |
| Human bocavirus | — | 1 (0.4) |
Figure 1Respiratory viruses identified in pediatric outpatients in southern Brazil in 2010 and 2011.
Influenza Vaccination in Pediatric Outpatients Enrolled in the Study
| Immunization history | 2010 | 2011 |
|
|---|---|---|---|
| N = 248 (%) | N = 244 (%) | ||
| Yes (two doses of influenza vaccine) | 219 (88) | 60 (25) | <0.0001 |
| Monovalent influenza vaccine | 198 (90) | 1 (2) | |
| Trivalent influenza vaccine | 17 (8) | 54 (90) | |
| Unknown | 4 (2) | 5 (8) |
Impact of Infection by Human Rhinovirus, Adenovirus, Parainfluenza Virus, Influenza Virus, and Coronavirus in Outpatients Compared to That of Infection by Other Respiratory Viruses (N = 293)
| Human rhinovirus, n = 89 | |||||||
|---|---|---|---|---|---|---|---|
| Unadjusted analysis | Adjusted analysis | ||||||
| Characteristics | Positive HRV (%) | Negative HRV (%) | OR (95% CI) |
| OR (95% CI) |
| |
| Gender | |||||||
| Male/Female | 48/41 | 109/95 | 1.02 (0.50–1.91) | 1.000 | — | — | |
| Age (mean ± SD) | 36.83 (±0.94) | 37.19 (±1.06) | — | 0.665 | — | — | |
| Underlying medical conditions | |||||||
| Yes | 46 (52) | 49 (24) | 3.34 (1.77–5.06) | < | 3.17 (1.86–5.46) | < | |
| Asthma/bronchospasm | |||||||
| Yes | 34 (38) | 30 (15) | 3.59 (2.23–7.93) | < | — | — | |
| Clinical signs and symptoms* | |||||||
| Fever | |||||||
| Yes | 60 (67) | 171 (84) | 0.4 (0.22–0.71) |
| 0.43 (0.23–0.79) |
| |
| Myalgia | |||||||
| Yes | 1 (1) | 15 (7) | 0.14 (0.01–1.10) | 0.061 | — | — | |
| Cough | |||||||
| Yes | 65 (73) | 140 (69) | 1.24 (0.71–2.15) | 0.49 | — | — | |
*Only results with significant differences. HRV, human rhinovirus; AdV, human adenovirus; PIV, parainfluenza virus; FLU, influenza virus; CoV, coronavirus; OR, odds ratio; NA, not applicable.
Bold values, statistical differences.